(R)-4-((3R,5S,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-7-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid; 3?-Hydroxy-7-oxo-5?-cholan-24-oic Acid; 3?-Hydroxy-7-oxo-5?-cholanic Acid; 3?-Hydroxy-7-oxo-5?-cholanoic Acid; 3?-Hydroxy-7-oxo-5?-cholic Acid; 5?-Cholanic Acid-3?-ol-7-one; 7-Ketochenodeoxycholic Acid; 7-Ketolithocholic Acid; 7-Oxo-3?-hydroxycholan-24-oic Acid; 7-Oxolithocholic Acid; 7-Keto-Lithocholic Acid; NSC 226118; 3?-Hydroxy-7-oxo-5?-cholanic Acid; 3?-Hydroxy-7-oxo-5?-cholan-24-oic Acid; (3?,5?)-3-Hydroxy-7-oxo-cholan-24-oic Acid; Ursodeoxycholic Acid EP Impurity F;
Ursodeoxycholic Acid EP Impurity F is a fully characterized chemical compound used as a reference standard of API Ursodiol. The standard offered is compliant with regulatory guidelines. Ursodeoxycholic Acid EP Impurity F is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 4651-67-6
